Full Press Release Details
Blog Post
vivani | May 13, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Read More
Previous Article
Next Article
Blog Navigation
VANI Neutral Sentiment
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Key Takeaway: Vivani Medical has released its financial results for the first quarter of 2026. The report includes a business update, although specific details regarding financial performance or strategic initiatives were not provided in the article. The announcement is part of the company's ongoing communication with stakeholders.
Price reaction · baseline $1.16 (2026-05-13 close) · hit after-hours · clean, no other VANI news in the window
day 0 close · peak
+3.4%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight